Skip to main content

Advertisement

Log in

Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Purpose: Patients with chronic obstructive pulmonary disease (COPD) may be at higher risk for osteoporosis. The primary objective of this case-control study was to determine the prevalence of vertebral fractures among patients with COPD admitted to acute care compared with a gender- and age-matched control group. Subjects and methods: Subjects were identified by chart reviews from an acute care hospital in Hamilton, Ontario, in 1999, including patients who were over 50 years old. In total, 127 patients with ICD-9 codes specifying COPD were randomly selected and compared with 127 gender- and age-matched controls. Chest radiographs were interpreted by two radiologists who defined and graded vertebral fractures using Genant’s method. Medications taken, or prescribed at discharge, were recorded from charts. Results: The overall prevalence of at least one vertebral fracture was found to be 34/127 (26.8%) in the COPD patients compared with 30/127 (23.6%) in the controls (p=0.556). A significantly greater proportion of COPD patients had at least one severe vertebral fracture (OR=3.75, 95% CI 1.24 to 11.3). Review of hospital chest X-ray reports indicated that only 12 of 64 (18.8%) patients with vertebral fractures identified by the study radiologists actually had a vertebral fracture noted in the report. The proportion of COPD patients with vertebral fractures who were discharged on osteoporosis therapy was 5/27 (18.5%). There was a suggestion of lower lung function, as measured by forced vital capacity (FVC%), in patients with severe vertebral fractures (p=0.067). Conclusions: These data indicate that: (1) There is an increased proportion of COPD patients with severe vertebral fracture, and (2) Documentation and treatment of osteoporosis in acute care COPD patients is low. Therefore, there is a need to target this high-risk group for osteoporosis screening and potential clinical management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Genant HK, Cooper C, Poor G et al (1999) Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 259–264

  2. Cooper C, Melton LJ (1992) Vertebral fractures, how large is the silent epidemic? BMJ 304:793–794

    CAS  PubMed  Google Scholar 

  3. Klotzbeucher CM, Ross PD, Landsman PB et al (2000) Patients with prior fracture have an increased risk of future fracture: summary of literature and statistical synthesis. J Bone Miner Res 15:721–727

    CAS  PubMed  Google Scholar 

  4. Gross NJ (2001) Extrapulmonary effects of chronic obstructive pulmonary disease. Curr Opin Pulm Med 7:84–92

    CAS  PubMed  Google Scholar 

  5. Manolagas SC, Weinstein RS (1999) New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14:1061–1066

    CAS  PubMed  Google Scholar 

  6. Likert BP, Raiaz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352–364

    CAS  PubMed  Google Scholar 

  7. Ruegsegger P, Medici TC, Anliker M (1983) Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615–620

    CAS  PubMed  Google Scholar 

  8. Goldstein MF, Fallon JJ, Harning R (1999) Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 116:1733–1749

    Article  CAS  PubMed  Google Scholar 

  9. Jones A, Fay JK, Burr M et al (2002) Review: Inhaled corticosteroids for asthma or chronic osbstructive pulmonary disease do not increase bone loss. Cochrane Database Syst Rev 1

  10. Papaioannou A, Adachi JD, Parkinson W, Stephenson G, Bedard M (2001) Lengthy Hospitalization Associated with Vertebral Fractures Despite Control for Comorbid Conditions. Osteoporos Int 12(10):870–874

    Article  CAS  PubMed  Google Scholar 

  11. Genant HK, Jergas M, Palermo L et al (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11:984–996

    CAS  PubMed  Google Scholar 

  12. Dubois EF, Roder E, Dekhuijzen R, Zwinderman AE, Schweitzer DH (2002) Dual energy x-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. Chest 121:1456–1463

    Article  CAS  PubMed  Google Scholar 

  13. Walsh LJ, Wong CA, Oborne J et al (2001) Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 56:279–284

    Article  CAS  PubMed  Google Scholar 

  14. McEvoy CE, Ensrud KE, Bender E et al (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:704–709

    CAS  PubMed  Google Scholar 

  15. Riancho JA, Gonzalez Macias J, Delarco C et al (1987) Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax 42:962–966

    CAS  PubMed  Google Scholar 

  16. Jackson SA, Tenenhouse A, Robertson L et al (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11:680–687

    Article  CAS  PubMed  Google Scholar 

  17. Melton LJ III, Kan SH, Frye MA et al (1989) Epidemiology of vertebral fractures in women. Am J Epidemiol 129:1000–1011

    PubMed  Google Scholar 

  18. Leech JA, Dulberg C, Kellie S, Pattee L, Gay J (1990) Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis. 141:68–71

    Google Scholar 

  19. Schlaich C, Minne HW, Bruckner T et al (1998) Reduced pulmonary function in patients with spinal osteoporotic fracture. Osteoporos Int 8:261–267

    CAS  PubMed  Google Scholar 

  20. Kado DM, Browner WS, Palermo L et al (1999) Vertebral fractures and mortality in older women: a prospective study. Arch Intern Med 159:1215–1220

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Sonny Olatunji and Neil Hannigan for their assistance with data collection for the study and Bethany Giddings for her assistance with the project. We would also like to thank Procter & Gamble Pharmaceuticals for an educational grant-in-aid.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Papaioannou.

Additional information

This study was supported by a research grant from Procter & Gamble Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papaioannou, A., Parkinson, W., Ferko, N. et al. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 14, 913–917 (2003). https://doi.org/10.1007/s00198-003-1449-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-003-1449-5

Keywords

Navigation